These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37460537)

  • 1. Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England.
    Perez-Guzman PN; Knock E; Imai N; Rawson T; Elmaci Y; Alcada J; Whittles LK; Thekke Kanapram D; Sonabend R; Gaythorpe KAM; Hinsley W; FitzJohn RG; Volz E; Verity R; Ferguson NM; Cori A; Baguelin M
    Nat Commun; 2023 Jul; 14(1):4279. PubMed ID: 37460537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
    Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
    Sonabend R; Whittles LK; Imai N; Perez-Guzman PN; Knock ES; Rawson T; Gaythorpe KAM; Djaafara BA; Hinsley W; FitzJohn RG; Lees JA; Kanapram DT; Volz EM; Ghani AC; Ferguson NM; Baguelin M; Cori A
    Lancet; 2021 Nov; 398(10313):1825-1835. PubMed ID: 34717829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian reconstruction of household transmissions to infer the serial interval of COVID-19 by variants of concern: analysis from a prospective community cohort study (Virus Watch).
    Geismar C; Nguyen V; Fragaszy E; Shrotri M; Navaratnam AMD; Beale S; Byrne TE; Fong WLE; Yavlinsky A; Kovar J; Braithwaite I; Aldridge RW; Hayward AC; White P; Jombart T; Cori A
    Lancet; 2022 Nov; 400 Suppl 1():S40. PubMed ID: 36929985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
    Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England.
    Knock ES; Whittles LK; Lees JA; Perez-Guzman PN; Verity R; FitzJohn RG; Gaythorpe KAM; Imai N; Hinsley W; Okell LC; Rosello A; Kantas N; Walters CE; Bhatia S; Watson OJ; Whittaker C; Cattarino L; Boonyasiri A; Djaafara BA; Fraser K; Fu H; Wang H; Xi X; Donnelly CA; Jauneikaite E; Laydon DJ; White PJ; Ghani AC; Ferguson NM; Cori A; Baguelin M
    Sci Transl Med; 2021 Jul; 13(602):. PubMed ID: 34158411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Immunity to Pre-Omicron and Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Variants in US States and Counties Through 1 December 2021.
    Klaassen F; Chitwood MH; Cohen T; Pitzer VE; Russi M; Swartwood NA; Salomon JA; Menzies NA
    Clin Infect Dis; 2023 Feb; 76(3):e350-e359. PubMed ID: 35717642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Principles of SARS-CoV-2 Intervariant Competition Are Exemplified in the Pre-Omicron Era of the Colombian Epidemic.
    Orf GS; Pérez LJ; Ciuoderis K; Cardona A; Villegas S; Hernández-Ortiz JP; Baele G; Mohaimani A; Osorio JE; Berg MG; Cloherty GA
    Microbiol Spectr; 2023 Jun; 11(3):e0534622. PubMed ID: 37191534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
    Nyberg T; Ferguson NM; Nash SG; Webster HH; Flaxman S; Andrews N; Hinsley W; Bernal JL; Kall M; Bhatt S; Blomquist P; Zaidi A; Volz E; Aziz NA; Harman K; Funk S; Abbott S; ; Hope R; Charlett A; Chand M; Ghani AC; Seaman SR; Dabrera G; De Angelis D; Presanis AM; Thelwall S
    Lancet; 2022 Apr; 399(10332):1303-1312. PubMed ID: 35305296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021.
    Klaassen F; Chitwood MH; Cohen T; Pitzer VE; Russi M; Swartwood NA; Salomon JA; Menzies NA
    medRxiv; 2022 Mar; ():. PubMed ID: 34981078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England.
    Allen H; Tessier E; Turner C; Anderson C; Blomquist P; Simons D; Løchen A; Jarvis CI; Groves N; Capelastegui F; Flannagan J; Zaidi A; Chen C; Rawlinson C; Hughes GJ; Chudasama D; Nash S; Thelwall S; Lopez-Bernal J; Dabrera G; Charlett A; Kall M; Lamagni T
    Epidemiol Infect; 2023 Mar; 151():e58. PubMed ID: 36938806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China.
    Wang K; Guo Z; Zeng T; Sun S; Lu Y; Wang J; Li S; Luan Z; Li H; Zhang J; Wang Y; Lu Y; Zhao S
    JAMA Netw Open; 2023 Mar; 6(3):e235755. PubMed ID: 36995713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.
    Lambrou AS; Shirk P; Steele MK; Paul P; Paden CR; Cadwell B; Reese HE; Aoki Y; Hassell N; Zheng XY; Talarico S; Chen JC; Oberste MS; Batra D; McMullan LK; Halpin AL; Galloway SE; MacCannell DR; Kondor R; Barnes J; MacNeil A; Silk BJ; Dugan VG; Scobie HM; Wentworth DE; Caravas J; Kovacs NA; Gerhart JG; Jia Ng H; Beck A; Chau R; Cintron R; Cook PW; Gulvik CA; Howard D; Jang Y; Knipe K; Lacek KA; Moser KA; Paskey AC; Rambo-Martin BL; Nagilla RR; Retchless AC; Schmerer MW; Seby S; Shepard SS; Stanton RA; Stark TJ; Uehara A; Unoarumhi Y; Bentz ML; Burgin A; Burroughs M; Davis ML; Keller MW; Keong LM; Le SS; Lee JS; Madden Jr JC; Nobles S; Owuor DC; Padilla J; Sheth M; Wilson MM; ;
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):206-211. PubMed ID: 35143464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical modeling of SARS-CoV-2 variant substitutions in European countries: transmission dynamics and epidemiological insights.
    de Rioja VL; Perramon-Malavez A; Alonso S; Andrés C; Antón A; Bordoy AE; Càmara J; Cardona PJ; Català M; López D; Martí S; Martró E; Saludes V; Prats C; Alvarez-Lacalle E
    Front Public Health; 2024; 12():1339267. PubMed ID: 38855458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England.
    Elliott P; Eales O; Bodinier B; Tang D; Wang H; Jonnerby J; Haw D; Elliott J; Whitaker M; Walters CE; Atchison C; Diggle PJ; Page AJ; Trotter AJ; Ashby D; Barclay W; Taylor G; Ward H; Darzi A; Cooke GS; Chadeau-Hyam M; Donnelly CA
    Nat Commun; 2022 Aug; 13(1):4500. PubMed ID: 35922409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airborne virus shedding of the alpha, delta, omicron SARS-CoV-2 variants and influenza virus in hospitalized patients.
    Ong DSY; de Man P; Verhagen T; Doejaaren G; Dallinga MA; Alibux E; Janssen ML; Wils EJ
    J Med Virol; 2023 Apr; 95(4):e28748. PubMed ID: 37185846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the serial intervals of SARS-CoV-2 Omicron BA.4, BA.5, and BA.2.12.1 variants in Hong Kong.
    Guo Z; Zhao S; Yam CHK; Li C; Jiang X; Chow TY; Chong KC; Yeoh EK
    Influenza Other Respir Viruses; 2023 Feb; 17(2):e13105. PubMed ID: 36824395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis.
    Xu X; Wu Y; Kummer AG; Zhao Y; Hu Z; Wang Y; Liu H; Ajelli M; Yu H
    BMC Med; 2023 Sep; 21(1):374. PubMed ID: 37775772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.